DegenRx

    OverviewSuggest Edit

    DegenRx is a biotech company developing AAV-mediated gene therapy for the treatment of CNS diseases such as Alzheimer’s and Parkinson’s disease. It uses Adeno-Associated-Viral (AAV) vectors to deliver genes in the brain that initiate the local production of therapeutic antibodies.
    TypePrivate
    Founded2018
    HQTilburg, NL
    Websitedegenrx.com

    Locations

    DegenRx is headquartered in
    Tilburg, Netherlands

    Location Map

    Latest Updates

    Employees (est.) (Jan 2022)2
    Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
    Banner background

    DegenRx Office Locations

    DegenRx has an office in Tilburg
    Tilburg, NL (HQ)
    Maidstone 48a
    Show all (1)

    DegenRx Financials and Metrics

    Summary Metrics

    Founding Date

    2018

    DegenRx Online and Social Media Presence

    Embed Graph

    DegenRx Frequently Asked Questions

    • When was DegenRx founded?

      DegenRx was founded in 2018.

    • How many employees does DegenRx have?

      DegenRx has 2 employees.

    • Who are DegenRx competitors?

      Competitors of DegenRx include apceth Biopharma, ToolGen and Gyroscope Therapeutics.

    • Where is DegenRx headquarters?

      DegenRx headquarters is located at Maidstone 48a, Tilburg.

    • Where are DegenRx offices?

      DegenRx has an office in Tilburg.

    • How many offices does DegenRx have?

      DegenRx has 1 office.